Browse > Article

Pharmacological and electrophysiological characterization of rat P2X currents  

Li, Hai-Ying (Department of Physiology and Program in Molecular and Cellular Neuroscience, School of Dentistry and Dental Research Institute, Seoul National University)
Oh, Seog-Bae (Department of Physiology and Program in Molecular and Cellular Neuroscience, School of Dentistry and Dental Research Institute, Seoul National University)
Kim, Joong-Soo (Department of Physiology and Program in Molecular and Cellular Neuroscience, School of Dentistry and Dental Research Institute, Seoul National University)
Publication Information
International Journal of Oral Biology / v.33, no.1, 2008 , pp. 1-5 More about this Journal
Abstract
Adenosine 5'-triphosphate (ATP) is an important extracellular signaling molecule which is involved in a variety of physiological responses in many different tissues and cell types, by acting at P2 receptors, either ionotropic (P2X) or G protein-coupled metabotropic receptors (P2Y). P2X receptors have seven isoforms designated as $P2X_{1^-}P2X_7$. In this study, we investigated the electrophysiological and pharmacological properties of rat $P2X_{1^-}P2X_4$ currents by using whole-cell patch clamp technique in a heterologous expression system. When ATP-induced currents were analyzed in human embryonic kidney (HEK293) cells following transient transfection of rat $P2X_{1^-}P2X_4$, the currents showed different pharmacological and electrophysiological properties. ATP evoked inward currents with fast activation and fast desensitization in $P2X_{^1-}$ or $P2X_{3^-}$ expressing HEK293 cells, but in $P2X_{2^-}$ or $P2X_{4^-}$ expressing HEK293 cells, ATP evoked inward currents with slow activation and slow desensitization. While PPADS and suramin inhibited $P2X_2$ or $P2X_3$ receptor-mediated currents, they had little effects on $P2X_4$ receptor-mediated currents. Ivermectin potentiated and prolonged $P2X_4$ receptor-mediated currents, but did not affect $P2X_2$ or $P2X_3$ receptor-mediated currents. We suggest that distinct pharmacological and electrophysiological properties among P2X receptor subtypes would be a useful tool to determine expression patterns of P2X receptors in the nervous system including trigeminal sensory neurons and microglia.
Keywords
ATP; ivermectin; P2X receptors; PPADS; surarmin;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bianchi B.R., Lynch K.J., Touma E, Niforatos W, Burgard E.C., Alexander K.M., Park H.S., Yu H, Metzger R, Kowaluk E, Jarvis M.F., van Biesen T.: Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol. 376:127-38, 1999   DOI   ScienceOn
2 Bo X, Zhang Y, Nassar M, Burnstock G, Schoepfer R.: A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett. 375:129-33, 1995   DOI   ScienceOn
3 Ikeda M, Characterization of functional P2X(1) receptors in mouse megakaryocytes. Thromb Res. 119:343-53, 2007   DOI   ScienceOn
4 North R.A.: Molecular physiology of P2X receptors. Physiol Rev. 82:1013-67, 2002   DOI
5 North R.A., Surprenant A.: Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol. 40:563-80, 2000   DOI   ScienceOn
6 Toulme E, Soto F, Garret M, Boue-Grabot E.: Functional properties of internalization-deficient P2X4 receptors reveal a novel mechanism of ligand-gated channel facilitation by ivermectin. Mol Pharmacol. 69:576-87, 2006   DOI   ScienceOn
7 Ralevic V, Burnstock G.: Receptors for purines and pyrimidines. Pharmacol Rev. 50:413-92, 1998
8 Dutton JL, Poronnik P, Li GH, Holding CA, Worthington RA, Vandenberg RJ, Cook DI, Barden JA, Bennett MR.: P2X(1) receptor membrane redistribution and down-regulation visualized by using receptor-coupled green fluorescent protein chimeras. Neuropharmacology. 23;39:2054-66, 2000
9 Woodward JJ, Nowak M, Davies DL.: Effects of the abused solvent toluene on recombinant P2X receptors expressed in HEK293 cells. Mol Brain Res. 125:86-95, 2004   DOI   ScienceOn
10 Jones C.A., Chessell I.P., Simon J, Barnard E.A., Miller K.J., Michel A.D., and Humphrey P.P.: Functional characterization of the P2X4 receptor orthologues. Br J Pharmacol. 129: 388-394, 2000   DOI   ScienceOn
11 Burnstock G.: Purinergic P2 receptors as targets for novel analgesics. Pharmacol Ther. 110:433-54, 2006   DOI   ScienceOn
12 Boeynaems J.M., Communi D, Gonzalez N.S., Robaye B.: Overview of the P2 receptors. Semin Thromb Hemost. 31:139-49, 2005   DOI   ScienceOn
13 Evans R.J., Lewis C, Buell G, Valera S, North R.A., Surprenant A.: Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X purinoceptors). Mol Pharmacol. 48:178-83, 1995
14 Khakh B.S., North R.A.: P2X receptors as cell-surface ATP sensors in health and disease. Nature. 442:527-32, 2006   DOI   ScienceOn
15 Priel A, Silberberg S.D.: Mechanism of ivermectin facilitation of human P2X4 receptor channels. J Gen Physiol. 123: 281-293, 2004   DOI   ScienceOn
16 Burgard E.C., Niforatos W, van Biesen T, Lynch K.J., Touma E, Metzger R.E., Kowaluk E.A., Jarvis M.F.: P2X receptormediated ionic currents in dorsal root ganglion neurons. J Neurophysiol. 82:1590-8, 1999   DOI
17 Townsend-Nicholson A, King B.F., Wildmann S.S., and Burnstock G. Molecular cloning, functional characterization and possible cooperativity between murine P2X4 and P2X4a receptors. Mol Brain Res. 64: 246-254, 1999   DOI   ScienceOn
18 Hamilton SG.: ATP and pain. Pain Pract. 2:289-94, 2002   DOI   ScienceOn
19 Sim J.A., Park C.K., Oh S.B., Evans R.J., North R.A.: P2X(1) and P2X(4) receptor currents in mouse macrophages. Br J Pharmacol. 152:1283-90, 2007   DOI   ScienceOn
20 Burnstock G.: Purine and pyrimidine receptors. Cell Mol Life Sci. 64:1471-83, 2007b   DOI
21 Burnstock G.: Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev. 87:659-797, 2007a   DOI   ScienceOn